Candidate Plasma Biomarkers to Detect Anthracycline‐Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study

MLA

Jan M. Leerink, et al. “Candidate Plasma Biomarkers to Detect Anthracycline‐Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, vol. 11, no. 14, July 2022. EBSCOhost, https://doi.org/10.1161/JAHA.121.025935.

APA

Jan M. Leerink, Elizabeth A. M. Feijen, Perry D. Moerland, Esmee C. de Baat, Remy Merkx, Helena J. H. van der Pal, Wim J. E. Tissing, Marloes Louwerens, Marry M. van den Heuvel‐Eibrink, A. Birgitta Versluys, Folkert W. Asselbergs, Arjan Sammani, Arco J. Teske, Elvira C. van Dalen, Margriet van der Heiden‐van der Loo, Eline van Dulmen‐den Broeder, Andrica C. H. de Vries, Livia Kapusta, Jacqueline Loonen, … Wouter E. M. Kok. (2022). Candidate Plasma Biomarkers to Detect Anthracycline‐Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 11(14). https://doi.org/10.1161/JAHA.121.025935

Chicago

Jan M. Leerink, Elizabeth A. M. Feijen, Perry D. Moerland, Esmee C. de Baat, Remy Merkx, Helena J. H. van der Pal, Wim J. E. Tissing, et al. 2022. “Candidate Plasma Biomarkers to Detect Anthracycline‐Related Cardiomyopathy in Childhood Cancer Survivors: A Case Control Study in the Dutch Childhood Cancer Survivor Study.” Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 11 (14). doi:10.1161/JAHA.121.025935.